Lv1
60 积分 2025-08-08 加入
Inhibition of Interleukin-1β and Reduction in Atherothrombotic Cardiovascular Events in the CANTOS Trial
5天前
已完结
Firsekibart versus compound betamethasone in acute gout patients unsuitable for standard therapy: A randomized phase 3 trial
5天前
已完结
A genome-wide association analysis reveals new pathogenic pathways in gout
5天前
已完结
Factors beyond urate levels for managing gout flares
5天前
已完结
Rational design of an NLRP3 inhibitor with superior efficacy and safety for gout therapy
6天前
已完结
Discovery of DFV890, a Potent Sulfonimidamide-Containing NLRP3 Inflammasome Inhibitor
6天前
已完结
Targeting the NLRP3 inflammasome as a novel therapeutic target for osteoarthritis
6天前
已完结
NLRP3 as a potentially novel biomarker for the management of osteoarthritis
6天前
已完结
Development of a highly potent and selective degrader of LRRK2
11天前
已完结
MCC950 in the treatment of NLRP3-mediated inflammatory diseases: Latest evidence and therapeutic outcomes
11天前
已完结
皖公网安备34019202002308
